You are here

Spinraza

Roche, PTC post latest SMA data from their attempt to rival Spinraza, Zolgensma

Fierce Biotech

Tue, 05/7/19 - 10:19 am

PTC Therapeutics

spinal muscular atrophy

New Zolgensma data suggest comparable efficacy to Spinraza — analysts

Endpoints

Mon, 05/6/19 - 09:52 pm

spinal muscular atrophy

Should Biogen Investors Be Extra Nervous Right Now?

Motley Fool

Sun, 04/7/19 - 05:08 pm

Alzheimer's disease

ICER says gene therapy may be more cost effective for spinal muscular atrophy

Yahoo/Reuters

Thu, 12/20/18 - 11:54 pm

spinal muscular atrophy

Researchers behind Biogen’s breakthrough drug win big at ‘Oscars of science’

Stat

Thu, 10/18/18 - 12:14 am

Biogen's new Spinraza data for earlier use 'pretty amazing,' analyst says

Fierce Pharma

Mon, 10/8/18 - 11:37 pm

spinal muscular atrophy

Biogen's Spinraza gets an early no-go from NICE

Biopharma Dive

Wed, 08/15/18 - 09:57 am

spinal muscular atrophy

Why Biogen's Stock Ripped Higher in July

Motley Fool

Mon, 08/13/18 - 09:41 am

Alzheimer's disease

Ionis Pharmaceuticals

Biogen’s Spinraza Sales Slow as AveXis and Novartis Pursue SMA Gene Therapy

Xtalks

Fri, 04/27/18 - 10:03 am

spinal muscular atrophy

Biogen faces increased 'pressure' after AveXis buyout by Novartis

Marketwatch

Mon, 04/9/18 - 09:10 am

Will 2018 Be Ionis Pharmaceuticals, Inc.'s Best Year Yet?

Motley Fool

Sat, 01/13/18 - 10:43 pm

Ionis Pharmaceuticals

Biogen Unlikely To See Spinraza Rival In 2018 As AveXis Delayed

Investors Business Daily

Fri, 01/5/18 - 05:44 pm

spinal muscular atrophy

Biogen, Ionis looking for new SMA drugs following Spinraza's success

BioPharma Dive

Wed, 12/20/17 - 11:05 pm

Ionis Pharmaceuticals

NEJM publishes Phase III results for Biogen/Ionis’ Spinraza

GoinPharma

Mon, 11/6/17 - 08:56 am

Ionis Pharmaceuticals

clinical trials

spinal muscular atrophy

US Spinraza sales cause concern among Biogen investors

Biopharma Dive

Wed, 10/25/17 - 09:40 am

spinal muscular atrophy

Spinraza launch set for blockbuster trajectory

BioPharma Dive

Wed, 07/26/17 - 12:11 am

spinal muscular atrophy

For Biogen's Spinraza launch, things are looking up on the coverage front: analyst

Fierce Pharma

Thu, 07/20/17 - 10:11 am

spinal muscular atrophy

PTC and Roche report solid data for Spinraza rival

BioPharma Dive

Wed, 07/5/17 - 06:55 pm

PTC Therapeutics

spinal muscular atrophy

Biogen’s Spinraza Witnessed Robust Patient Demand in 1Q17

Market Realist

Fri, 04/28/17 - 11:45 am

spinal muscular atrophy

Hyde Park boy with rare disease wins appeal, will receive Biogen drug

Bizjournals.com

Wed, 04/26/17 - 09:35 pm

spinal muscular atrophy

Pages